Department of Medical Science, Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea.
Department of Biochemistry, Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea.
Int J Mol Sci. 2023 Feb 7;24(4):3322. doi: 10.3390/ijms24043322.
The highly dynamic changes in microglia necessary to achieve a rapid neuroinflammatory response require a supply of energy from mitochondrial respiration, which leads to the accumulation of unfolded mitochondrial proteins. We previously reported that microglial activation is correlated with the mitochondrial unfolded protein response (UPRmt) in a kaolin-induced hydrocephalus model, but we still do not know the extent to which these changes in microglia are involved in cytokine release. Here, we investigated the activation of BV-2 cells and found that treatment with lipopolysaccharide (LPS) for 48 h increased the secretion of pro-inflammatory cytokines. This increase was accompanied by a concurrent decrease in oxygen consumption rate (OCR) and mitochondrial membrane potential (MMP), in association with the up-regulation of the UPRmt. Inhibition of the UPRmt by knockdown of ATF5, a key upstream regulator of the UPRmt, using small-interfering RNA against ATF5 (siATF5) not only increased production of the pro-inflammatory cytokines, interleukin-6 (IL-6), IL-1β and tumor necrosis factor-α (TNF-α), but also decreased MMP. Our results suggest that ATF5-dependent induction of the UPRmt in microglia acts as a protective mechanism during neuroinflammation and may be a potential therapeutic target for reducing neuroinflammation.
小胶质细胞的高度动态变化是快速神经炎症反应所必需的,需要线粒体呼吸提供能量,这导致未折叠的线粒体蛋白积累。我们之前报道过,在高岭土诱导的脑积水模型中,小胶质细胞的激活与线粒体未折叠蛋白反应(UPRmt)相关,但我们仍不清楚小胶质细胞的这些变化在多大程度上参与细胞因子的释放。在这里,我们研究了 BV-2 细胞的激活,发现用脂多糖(LPS)处理 48 小时会增加促炎细胞因子的分泌。这种增加伴随着耗氧率(OCR)和线粒体膜电位(MMP)的同时下降,与 UPRmt 的上调有关。使用针对 ATF5 的小干扰 RNA(siATF5)抑制 UPRmt 的关键上游调节剂 ATF5 的敲低不仅增加了促炎细胞因子白细胞介素 6(IL-6)、白细胞介素 1β(IL-1β)和肿瘤坏死因子-α(TNF-α)的产生,还降低了 MMP。我们的结果表明,小胶质细胞中 ATF5 依赖性 UPRmt 的诱导在神经炎症中起着保护机制的作用,可能是减少神经炎症的潜在治疗靶点。